Sarah C. Darby

Roosevelt Drive
Oxford, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 78 publications

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Maintenance rucaparib after first-line platinum-based chemotherapy in HER2-negative advanced oesophagogastric adenocarcinoma: results from the PLATFORM study.

Journal: ESMO open

Published: March 24, 2026

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

Second cancers in 475 000 women with early invasive breast cancer diagnosed in England during 1993-2016: population based observational cohort study.

Journal: BMJ (Clinical research ed.)

Published: August 27, 2025

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Causes of excess non-lymphoma death in 58,000 patients with DLBCL diagnosed during 1997-2020 and followed for up to 25 years.

Journal: Blood advances

Published: August 01, 2025

Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.

Causes of excess nonlymphoma death in 58 000 patients with DLBCL diagnosed during 1997 to 2020 and followed for up to 25 years.

Journal: Blood advances

Published: August 01, 2025

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016.

Histological types of invasive breast cancer in 830,000 women diagnosed in England during 1988-2016.

Journal: The journal of pathology. Clinical research

Published: February 12, 2025

Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England.

Identification of recurrences in women diagnosed with early invasive breast cancer using routinely collected data in England.

Journal: BJC reports

Published: October 15, 2024

Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study.

Maintenance durvalumab after first-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study.

Journal: ESMO open

Published: March 19, 2024

Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.

Invasive breast cancer and breast cancer death after non-screen detected ductal carcinoma in situ from 1990 to 2018 in England: population based cohort study.

Journal: BMJ (Clinical research ed.)

Published: January 24, 2024

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Estimated Doses to the Heart, Lungs and Oesophagus and Risks From Typical UK Radiotherapy for Early Breast Cancer During 2015-2023.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))

Published: January 06, 2024

Authors' reply to Oke and Welch.

Authors' reply to Oke and Welch.

Journal: BMJ (Clinical research ed.)

Published: September 13, 2023

Evaluating the social benefits and network costs of heat pumps as an energy crisis intervention.

Evaluating the social benefits and network costs of heat pumps as an energy crisis intervention.

Journal: iScience

Published: August 04, 2023

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Breast cancer mortality in 500 000 women with early invasive breast cancer diagnosed in England, 1993-2015: population based observational cohort study.

Journal: BMJ (Clinical research ed.)

Published: June 13, 2023

Showing 1-12 of 78

Last Updated: 09/26/2026